Hirzebruch Research Instructor at the University of Bonn and Max Planck Institute for Mathematics, received the 2025 Maryam Mirzakhani New Frontiers Prize for her research at the intersection of harmonic analysis and number theory.
University of California, Berkeley (PhD, University of Washington 2023), receives the 2025 Maryam Mirzakhani New Frontiers Prize for developing classical analogs of quantum algorithms for machine learning and linear algebra, as well as advancing quantum machine learning on quantum data.
Of the Novo Nordisk Foundation Center for Basic Metabolic Research and the Department of Biomedical Sciences at the University of Copenhagen accepted the 2025 Breakthrough Prize in Life Sciences for his discovery and detailed study of GLP-1, uncovering its role in the body and its potential in treating diabetes and obesity.
CERN spokesperson from 2021 to 2025, accepted the 2025 Breakthrough Prize in Fundamental Physics on behalf of the ATLAS Collaboration. The award recognizes the team’s groundbreaking work, including precise measurements of the Higgs boson, discoveries of new strongly interacting particles, studies of rare processes and matter-antimatter asymmetry, and exploration of nature at the smallest scales using CERN’s Large Hadron Collider.
Spokesperson for the ALICE Collaboration from 2023 to 2025, accepted the 2025 Breakthrough Prize in Fundamental Physics on behalf of the team. The collaboration was recognized for groundbreaking measurements of the Higgs boson, discoveries of new strongly interacting particles, and studies of rare processes and matter-antimatter asymmetry at CERN’s Large Hadron Collider.
Spokesperson of the LHCb Collaboration (INFN Bologna, 2023–2026), accepted the 2025 Breakthrough Prize in Fundamental Physics on behalf of the team. The award honors their detailed measurements of Higgs boson properties, discoveries of new particles, and studies of matter–antimatter asymmetry at CERN’s Large Hadron Collider.
Of Harvard University receives the 2025 Breakthrough Prize in Life Sciences for establishing the role of B cells in multiple sclerosis, developing B-cell–based treatments, and revealing that Epstein-Barr virus infection is the leading risk factor for the disease.
